Guest column

Houston has what it takes to emerge as a smart city leader, expert says

Houston real estate expert shares why he thinks the city is prime for smart city tech and implementation. Photo via Getty Images

While Houston has long been known as the Energy Capital of the World, there’s no reason we, as a city, cannot hold more than one title. What if Houston could take on the title of Smartest City in the World?

There are many factors that create a smart city, and it is deeper than just implementing new smart technology – it is a city that better supports the lifestyles of its residents seamlessly and unobtrusively. To effectively understand what the needs of the community are and the right types of technologies to implement when urban planning, data collection and data security measures are vital.

The City of Houston has already begun to use data and emerging technology to improve the quality of life for citizens, share information with the public, drive economic growth, and build a more inclusive society. To be successful and provide enriching experiences for Houstonians, these updates must happen at the infrastructure level, working as an integrated system that can be continuously optimized.

In 2015, Houston adopted an Open Data policy to support data sharing efforts between the government, its citizens, businesses and researchers. In addition to this, our city has made strategic investments in artificial intelligence, the Cloud, the Edge, smart sensors, big data, and more. These investments are being bolstered by private companies and institutions, building on these technologies to tackle urban problems, identify better solutions and enact privacy protections. These companies, such as McCord, are helping execute the city’s vision around development, transportation, public safety and community engagement.

Houston already has a case study

Citizens also play an active role in building the future of Houston through their behaviors and consumption patterns.

Take Generation Park, one of the largest privately held commercial developments in the country, sitting on 4,200 contiguous acres in Northeast Houston. As this land continues to be built out, developers at McCord partnered with Bosch technologies to implement sensors and other smart technologies to better understand how visitors are utilizing the trails, parking and space. These insights will then help McCord recognize parking patterns or which areas of the trails are most heavily trafficked, allowing the company to make more informed decisions regarding maintenance and infrastructure updates, ultimately providing a better experience for their visitors.

The data can also be factored in when planning events for the community. McCord will be able to use the data collected to determine things like the optimal times, preferred days and the need for parking at Redemption Square.

But the data use doesn’t stop at just events - tenants can use it to determine when to expect the dinner rush and apply that to staffing, prepping, happy hour specials and ultimately, factor it into better servicing their customers. Those living at Redemption Square’s 255 Assay Luxury Apartments will also benefit as McCord uses data trends to optimize their curbside management practices to better accommodate rideshare and food delivery services.

The plans for Redemption Square and Generation Park continue to adapt as data is collected and visitor behavior better understood. The goal of this data collection is to make Generation Park a citizen-optimized environment via cutting-edge technology where residents, visitors, employees, and businesses will thrive while knowing that their privacy is not at risk.

The bottom line

Houston’s diversity, business-friendly environment, and workforce make it a prime candidate to become a smart city. Becoming smarter in our transportation, public safety, sustainability practices, and infrastructure will create a better future for Houstonians.

Creating secure, holistic systems that work and learn together is central to successful smart city infrastructure. Private and public organizations must work together to collect data, pivot plans when needed and implement the correct technologies to ensure that these efforts ultimately make Houston a better place to live.

------

Ryan McCord is president of Houston-based McCord Development.

Trending News

Building Houston

 
 

A Rice research team is tapping into materials science to better understand Alzheimer’s disease, a UH professor is developing a treatment for hereditary vision loss, and a BCM researcher is looking at stress and brain cancer. Photo by Gustavo Raskosky/Rice University

Research, perhaps now more than ever, is crucial to expanding and growing innovation in Houston — and it's happening across the city right under our noses.

In InnovationMap's latest roundup of research news, three Houston institutions are working on life-saving health care research thanks to new technologies.

Rice University scientists' groundbreaking alzheimer's study

Angel Martí (right) and his co-authors (from left) Utana Umezaki and Zhi Mei Sonia He have published their latest findings on Alzheimer’s disease. Photo by Gustavo Raskosky/Rice University

According to the Centers for Disease Control and Prevention, Alzheimer’s disease will affect nearly 14 million people in the U.S. by 2060. A group of scientists from Rice University are looking into a peptide associated with the disease, and their study was published in Chemical Science.

Angel Martí — a professor of chemistry, bioengineering, and materials science and nanoengineering and faculty director of the Rice Emerging Scholars Program — and his team have developed a new approach using time-resolved spectroscopy and computational chemistry, according to a news release from Rice. The scientists "found experimental evidence of an alternative binding site on amyloid-beta aggregates, opening the door to the development of new therapies for Alzheimer’s and other diseases associated with amyloid deposits."

Amyloid plaque deposits in the brain are a main feature of Alzheimer’s, per Rice.

“Amyloid-beta is a peptide that aggregates in the brains of people that suffer from Alzheimer’s disease, forming these supramolecular nanoscale fibers, or fibrils” says Martí in the release. “Once they grow sufficiently, these fibrils precipitate and form what we call amyloid plaques.

“Understanding how molecules in general bind to amyloid-beta is particularly important not only for developing drugs that will bind with better affinity to its aggregates, but also for figuring out who the other players are that contribute to cerebral tissue toxicity,” he adds.

The National Science Foundation and the family of the late Professor Donald DuPré, a Houston-born Rice alumnus and former professor of chemistry at the University of Louisville, supported the research, which is explained more thoroughly on Rice's website.

University of Houston professor granted $1.6M for gene therapy treatment for rare eye disease

Muna Naash, a professor at UH, is hoping her research can result in treatment for a rare genetic disease that causes vision loss. Photo via UH.edu

A University of Houston researcher is working on a way to restore sight to those suffering from a rare genetic eye disease.

Muna Naash, the John S. Dunn Endowed Professor of biomedical engineering at UH, is expanding a method of gene therapy to potentially treat vision loss in patients with Usher Syndrome Type 2A, or USH2A, a rare genetic disease.

Naash has received a $1.6 million grant from the National Eye Institute to support her work. Mutations of the USH2A gene can include hearing loss from birth and progressive loss of vision, according to a news release from UH. Naash's work is looking at applying gene therapy — the introduction of a normal gene into cells to correct genetic disorders — to treat this genetic disease. There is not currently another treatment for USH2A.

“Our goal is to advance our current intravitreal gene therapy platform consisting of DNA nanoparticles/hyaluronic acid nanospheres to deliver large genes in order to develop safe and effective therapies for visual loss in Usher Syndrome Type 2A,” says Naash. “Developing an effective treatment for USH2A has been challenging due to its large coding sequence (15.8 kb) that has precluded its delivery using standard approaches and the presence of multiple isoforms with functions that are not fully understood."

BCM researcher on the impact of stress

This Baylor researcher is looking at the relationship between stress and brain cancer thanks to a new grant. Photo via Andriy Onufriyenko/Getty Images

Stress can impact the human body in a number of ways — from high blood pressure to hair loss — but one Houston scientist is looking into what happens to bodies in the long term, from age-related neurodegeneration to cancer.

Dr. Steven Boeynaems is assistant professor of molecular and human genetics at Baylor College of Medicine. His lab is located at the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, and he also is a part of the Therapeutic Innovation Center, the Center for Alzheimer’s and Neurodegenerative Diseases, and the Dan L Duncan Comprehensive Cancer Center at Baylor.

Recently, the Cancer Prevention and Research Institute of Texas, or CPRIT, awarded Boeynaems a grant to continue his work studying how cells and organisms respond to stress.

“Any cell, in nature or in our bodies, during its existence, will have to deal with some conditions that deviate from its ideal environment,” Boeynaems says in a BCM press release. “The key issue that all cells face in such conditions is that they can no longer properly fold their proteins, and that leads to the abnormal clumping of proteins into aggregates. We have seen such aggregates occur in many species and under a variety of stress-related conditions, whether it is in a plant dealing with drought or in a human patient with aging-related Alzheimer’s disease."

Now, thanks to the CPRIT funding, he says his lab will now also venture into studying the role of cellular stress in brain cancer.

“A tumor is a very stressful environment for cells, and cancer cells need to continuously adapt to this stress to survive and/or metastasize,” he says in the release.

“Moreover, the same principles of toxic protein aggregation and protection through protein droplets seem to be at play here as well,” he continues. “We have studied protein droplets not only in humans but also in stress-tolerant organisms such as plants and bacteria for years now. We propose to build and leverage on that knowledge to come up with innovative new treatments for cancer patients.”

Trending News